Evidence map›Paper›PMID 29926835›Full record

ArticleNeural regeneration research2018

Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer's disease.

Sara H Mokhtar, Min Joung Kim, Kylie A Magee, Pei Mun Aui, Speros Thomas, Maha M Bakhuraysah, Amani A Alrehaili, Jae Young Lee, David L Steer, Rachel Kenny and 7 more

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Interleukin-4 affects microglial autophagic flux.Neural regeneration research · 2019
    Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Sara H MokhtarDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Min Joung KimDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Kylie A MageeDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Pei Mun AuiDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Speros ThomasDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Maha M BakhuraysahDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Amani A AlrehailiDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Jae Young LeeDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
David L SteerDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
Rachel KennyDepartment of Anatomy & Developmental Biology, Monash University, Clayton, Victoria, Australia.
Catriona McLeanDepartment of Anatomical Pathology, Alfred Hospital, Prahran, Victoria, Australia.
Michael F AzariDepartment of Anatomy & Developmental Biology, Monash University, Clayton; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
Antonis BirpanagosDivision of Animal and Human Physiology, Department of Biology, National and Kapodistrian University of Athens, Ilisia, Athens, Greece.
Ewlina LipiecThe Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Department of Applied Spectroscopy, Radzikowskiego, Krakow, Poland.
Philip HeraudCentre for Biospectroscopy and Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Bayden WoodCentre for Biospectroscopy and Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Steven PetratosDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria, Australia.
Monash University · AUInstitute of Nuclear Physics, Polish Academy of Sciences · PLNational and Kapodistrian University of Athens · GRThe Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles. Prior to the development of these characteristic pathological hallmarks of AD, anterograde axonal transport is impaired. However, the key proteins that initiate these intracellular impairments remain elusive. The collapsin response mediator protein-2 (CRMP-2) plays an integral role in kinesin-1-dependent axonal transport and there is evidence that phosphorylation of CRMP-2 releases kinesin-1. Here, we tested the hypothesis that amyloid-beta (Aβ)-dependent phosphorylation of CRMP-2 disrupts its association with the kinesin-1 (an anterograde axonal motor transport protein) in AD. We found that brain sections and lysates from AD patients demonstrated elevated phosphorylation of CRMP-2 at the T555 site. Additionally, in the transgenic Tg2576 mouse model of familial AD (FAD) that exhibits Aβ accumulation in the brain with age, we found substantial co-localization of pT555CRMP-2 and dystrophic neurites. In SH-SY5Y differentiated neuronal cultures, Aβ-dependent phosphorylation of CRMP-2 at the T555 site was also elevated and this reduced the CRMP-2 association with kinesin-1. The overexpression of an unphosphorylatable form of CRMP-2 in neurons promoted the re-establishment of CRMP-2-kinesin association and axon elongation. These data suggest that Aβ-dependent phosphorylation of CRMP-2 at the T555 site may directly impair anterograde axonal transport protein function, leading to neuronal defects.

Indexed as

amyloid-beta proteincollapsin response mediator proteinkinaseskinesinmicrotubulestubulin

Identifiers

PMID29926835
PMCPMC6022475
OpenAlexW2808905191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.